Abstract:Fused tetrahydrocyclopenta-isoxazoles were synthesized by 1,3-dipolar cycloaddition reactions with pyridinealdoxime or tetrahydropyridinealdoxime and cycloalkenes.
“…Isoxazoles 4a and 4d were also prepared by using N ‐propargyl pyrrolidinone as the dipolarophile (Scheme ). Isoxazoline 3d and isoxazole 4d with 3‐pyridyl substituent were further reacted to give tetrahydropyridine substituted compounds 3e and 4e , respectively (Scheme ).…”
Section: Resultsmentioning
confidence: 99%
“…Several nitrogen containing heterocyclic esters 5a–5f were cyclized with 1‐(2‐oxopyrrolidin‐1‐yl)acetamidoxime by the action of NaH in the presence of 4 Å molecular sieves in dry THF to yield oxadiazoles 6a–6f . Methylation and subsequent reduction of the 3‐pyridyloxadiazole compound 6d gave the tetrahydropyridyloxadiazole compound 6g (Scheme ) . 1‐(2‐oxopyrrolidin‐1‐yl)acetamidoxime could be prepared by the reaction of N ‐cyanomethylpyrrolidin‐2‐one with hydroxylamine following the known procedure …”
Insertion of a methylene linker between the 2-pyrrolidinone substituent and the isoxazoline core of the lead compound 1 previously reported resulted in the loss of its agonistic activity. One exception was the compound 6f having oxadiazole core and 2-azabicyclo[2.2.1]heptane substituent. Of the two isomers of 6f, exo-isomer (EC 50 0.013 μM) was fiveto six-fold more effective than endo-isomer (EC 50 0.30 μM), and ca. two-fold active than the mother compound 1 (EC 50 0.031 μM) in stimulating the M 1 mAChR. Both isomers were moderately selective agonists for M 1 mAChR over the rest four subtypes, and it could be explained by docking study on active conformation allosteric binding sites of M 1 -M 5 mAChRs and calculating their binding energies.
“…Isoxazoles 4a and 4d were also prepared by using N ‐propargyl pyrrolidinone as the dipolarophile (Scheme ). Isoxazoline 3d and isoxazole 4d with 3‐pyridyl substituent were further reacted to give tetrahydropyridine substituted compounds 3e and 4e , respectively (Scheme ).…”
Section: Resultsmentioning
confidence: 99%
“…Several nitrogen containing heterocyclic esters 5a–5f were cyclized with 1‐(2‐oxopyrrolidin‐1‐yl)acetamidoxime by the action of NaH in the presence of 4 Å molecular sieves in dry THF to yield oxadiazoles 6a–6f . Methylation and subsequent reduction of the 3‐pyridyloxadiazole compound 6d gave the tetrahydropyridyloxadiazole compound 6g (Scheme ) . 1‐(2‐oxopyrrolidin‐1‐yl)acetamidoxime could be prepared by the reaction of N ‐cyanomethylpyrrolidin‐2‐one with hydroxylamine following the known procedure …”
Insertion of a methylene linker between the 2-pyrrolidinone substituent and the isoxazoline core of the lead compound 1 previously reported resulted in the loss of its agonistic activity. One exception was the compound 6f having oxadiazole core and 2-azabicyclo[2.2.1]heptane substituent. Of the two isomers of 6f, exo-isomer (EC 50 0.013 μM) was fiveto six-fold more effective than endo-isomer (EC 50 0.30 μM), and ca. two-fold active than the mother compound 1 (EC 50 0.031 μM) in stimulating the M 1 mAChR. Both isomers were moderately selective agonists for M 1 mAChR over the rest four subtypes, and it could be explained by docking study on active conformation allosteric binding sites of M 1 -M 5 mAChRs and calculating their binding energies.
Synthesis of 1,2,5,6-/1,2,3,6-Tetrahydropyridinyl-tetrahydrocyclopentaisoxazole Derivatives -[via 1,3-dipolar cycloaddition reactions of pyridinealdoxime derivatives with cycloalkenes]. -(AHN, M.; PARK, J. M.; LEE, I.-Y. C.; JUNG*, M. H.;
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.